共 78 条
[21]
Slattery M(2015)Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis Ann Surg 262 112-99
[22]
Lundgreen A(2012)Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials Eur J Cancer 48 1466-284
[23]
Wolff R(2010)Targeted therapy in advanced colorectal cancer: more data, more questions Anticancer Drugs 21 737-4632
[24]
Fang J(2009)BRAF mutation in metastatic colorectal cancer N Engl J Med 361 98-1805
[25]
Richardson B(2021)Encorafenib plus Cetuximab as a new standard of care for previously treated J Clin Oncol 39 273-undefined
[26]
Shahjehan F(2020) V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study J Clin Oncol 38 4015-undefined
[27]
Kamatham S(2011)FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable metastatic colorectal cancer (mCRC): a meta-analysis of individual patient data (IPD) from five randomized trials Cancer 117 4623-undefined
[28]
Chandrasekharan C(1999)Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer Br J Cancer 79 1800-undefined
[29]
Kasi P(undefined)Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma undefined undefined undefined-undefined
[30]
Liang J(undefined)undefined undefined undefined undefined-undefined